Dr. Gurpreet Singh (“Ray”) Walia is a partner in our New York office. He practices commercial and intellectual property litigation in a variety of disciplines, including pharmaceutical patent litigation and Hatch-Waxman litigation. He represents generic pharmaceutical companies in ANDA litigation. He also practices healthcare, regulatory, and compliance law.

Prior to law school, he completed his premedical education from Delhi University and earned a medical doctorate degree from Armed Forces Medical College, the second highest ranked medical school in India. After completing internal medicine and anesthesiology residencies at Johns Hopkins Health System and Albert Einstein College of Medicine, he practiced as an attending anesthesiologist physician in several American hospitals.

Dr. Walia earned his J.D. from St. John’s University School of Law where he served as Editor-in-Chief of the New York Real Property Law Journal, Articles & Notes Editor of the American Bankruptcy Institute Law Review, president of the Patent Law Society, and as a member of the Moot Court Honor Society. He previously represented branded pharmaceutical companies in ANDA litigation while ...